Daglioglu C - Search Results

1

Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy.

Rudzińska M, Daglioglu C, Savvateeva LV, Kaci FN, Antoine R, Zamyatnin AA Jr. Rudzińska M, et al. Among authors: daglioglu c. Drug Des Devel Ther. 2021 Jan 6;15:9-20. doi: 10.2147/DDDT.S285852. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 33442233 Free PMC article. Review.

2

Cascade therapy with doxorubicin and survivin-targeted tailored nanoparticles: An effective alternative for sensitization of cancer cells to chemotherapy.

Daglioglu C, Kaci FN. Daglioglu C, et al. Int J Pharm. 2019 Apr 20;561:74-81. doi: 10.1016/j.ijpharm.2019.02.036. Epub 2019 Feb 27. Int J Pharm. 2019. PMID: 30825555

3

The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance.

Rudzińska M, Parodi A, Soond SM, Vinarov AZ, Korolev DO, Morozov AO, Daglioglu C, Tutar Y, Zamyatnin AA Jr. Rudzińska M, et al. Among authors: daglioglu c. Int J Mol Sci. 2019 Jul 23;20(14):3602. doi: 10.3390/ijms20143602. Int J Mol Sci. 2019. PMID: 31340550 Free PMC article. Review.

4

Environmentally Responsive Dual-Targeting Nanoparticles: Improving Drug Accumulation in Cancer Cells as a Way of Preventing Anticancer Drug Efflux.

Daglioglu C. Daglioglu C. J Pharm Sci. 2018 Mar;107(3):934-941. doi: 10.1016/j.xphs.2017.10.029. Epub 2017 Oct 26. J Pharm Sci. 2018. PMID: 29107049

5

Therapeutic Effects of AICAR and DOX Conjugated Multifunctional Nanoparticles in Sensitization and Elimination of Cancer Cells via Survivin Targeting.

Daglioglu C, Okutucu B. Daglioglu C, et al. Pharm Res. 2017 Jan;34(1):175-184. doi: 10.1007/s11095-016-2053-7. Epub 2016 Oct 25. Pharm Res. 2017. PMID: 27783307

6

Synthesis and Characterization of AICAR and DOX Conjugated Multifunctional Nanoparticles as a Platform for Synergistic Inhibition of Cancer Cell Growth.

Daglioglu C, Okutucu B. Daglioglu C, et al. Bioconjug Chem. 2016 Apr 20;27(4):1098-111. doi: 10.1021/acs.bioconjchem.6b00080. Epub 2016 Mar 28. Bioconjug Chem. 2016. PMID: 26996194

7

Enhancing Tumor Cell Response to Multidrug Resistance with pH-Sensitive Quercetin and Doxorubicin Conjugated Multifunctional Nanoparticles.

Daglioglu C. Daglioglu C. Colloids Surf B Biointerfaces. 2017 Aug 1;156:175-185. doi: 10.1016/j.colsurfb.2017.05.012. Epub 2017 May 10. Colloids Surf B Biointerfaces. 2017. PMID: 28528134

8

Covalent immobilization of trypsin on glutaraldehyde-activated silica for protein fragmentation.

Daglioglu C, Zihnioglu F. Daglioglu C, et al. Artif Cells Blood Substit Immobil Biotechnol. 2012 Dec;40(6):378-84. doi: 10.3109/10731199.2012.686917. Epub 2012 Jun 6. Artif Cells Blood Substit Immobil Biotechnol. 2012. PMID: 22670793

9

Cloning, expression, and activity analysis of human cathepsin C in the yeast Pichia pastoris.

Dağlioğlu C. Dağlioğlu C. Turk J Biol. 2017 Nov 10;41(5):746-753. doi: 10.3906/biy-1704-4. eCollection 2017. Turk J Biol. 2017. PMID: 30814849 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page